Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

Clinical trial NCT04483674 · UNKNOWN

Trial details

NCT number: NCT04483674
Sponsor: Anna Cruceta
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Primary Infection

Start date: 2020-12-04
Primary completion: 2022-11-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.